SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-030634
Filing Date
2024-04-05
Accepted
2024-04-05 09:25:25
Documents
98
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0202804-6k_chinasxt.htm   iXBRL 6-K 16828
2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA ea020280401ex99-1_china.htm EX-99.1 122283
3 UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED S ea020280401ex99-2_china.htm   iXBRL EX-99.2 686538
4 GRAPHIC ex99-2_001.jpg GRAPHIC 50700
  Complete submission text file 0001213900-24-030634.txt   6398313

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE sxtc-20230930.xsd EX-101.SCH 90282
6 XBRL CALCULATION FILE sxtc-20230930_cal.xml EX-101.CAL 42946
7 XBRL DEFINITION FILE sxtc-20230930_def.xml EX-101.DEF 343394
8 XBRL LABEL FILE sxtc-20230930_lab.xml EX-101.LAB 602059
9 XBRL PRESENTATION FILE sxtc-20230930_pre.xml EX-101.PRE 353253
102 EXTRACTED XBRL INSTANCE DOCUMENT ea0202804-6k_chinasxt_htm.xml XML 753934
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 24824934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)